Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study.
Bangladesh
COVID-19
antibiotics
antimicrobial stewardship programs
children
guidelines
hospitals
outcomes
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
14 Jan 2022
14 Jan 2022
Historique:
received:
01
12
2021
revised:
04
01
2022
accepted:
11
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
There is an increasing focus on researching children admitted to hospital with new variants of COVID-19, combined with concerns with hyperinflammatory syndromes and the overuse of antimicrobials. Paediatric guidelines have been produced in Bangladesh to improve their care. Consequently, the objective is to document the management of children with COVID-19 among 24 hospitals in Bangladesh. Key outcome measures included the percentage prescribed different antimicrobials, adherence to paediatric guidelines and mortality rates using purposely developed report forms. The majority of 146 admitted children were aged 5 years or under (62.3%) and were boys (58.9%). Reasons for admission included fever, respiratory distress and coughing; 86.3% were prescribed antibiotics, typically parenterally, on the WHO 'Watch' list, and empirically (98.4%). There were no differences in antibiotic use whether hospitals followed paediatric guidance or not. There was no prescribing of antimalarials and limited prescribing of antivirals (5.5% of children) and antiparasitic medicines (0.7%). The majority of children (92.5%) made a full recovery. It was encouraging to see the low hospitalisation rates and limited use of antimalarials, antivirals and antiparasitic medicines. However, the high empiric use of antibiotics, alongside limited switching to oral formulations, is a concern that can be addressed by instigating the appropriate programmes.
Identifiants
pubmed: 35052982
pii: antibiotics11010105
doi: 10.3390/antibiotics11010105
pmc: PMC8772946
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080
pubmed: 34223139
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Lancet Infect Dis. 2019 Jan;19(1):67-75
pubmed: 30522834
Infect Control Hosp Epidemiol. 2012 Apr;33(4):362-7
pubmed: 22418631
Pharmaceuticals (Basel). 2021 Jul 28;14(8):
pubmed: 34451833
Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546
pubmed: 31257952
J Endocrinol Invest. 2021 Jan;44(1):27-35
pubmed: 32557271
Infect Prev Pract. 2021 Jun;3(2):100134
pubmed: 34316576
Antibiotics (Basel). 2021 Aug 04;10(8):
pubmed: 34438993
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Antibiotics (Basel). 2021 Jun 18;10(6):
pubmed: 34207020
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
Int J Antimicrob Agents. 2020 Dec;56(6):106189
pubmed: 33045348
Expert Rev Anti Infect Ther. 2021 Oct;19(10):1353-1366
pubmed: 33724147
J Biomed Inform. 2018 Aug;84:114-122
pubmed: 29981885
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
J Comp Eff Res. 2021 Aug;10(12):1019-1052
pubmed: 34241546
Pediatr Res. 2020 Nov;88(5):705-716
pubmed: 32634818
BMJ. 2020 Oct 19;371:m4057
pubmed: 33077424
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272
pubmed: 32687792
Expert Rev Anti Infect Ther. 2021 Jun;19(6):805-814
pubmed: 33034234
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Int J Infect Dis. 2019 Mar;80:54-61
pubmed: 30634043
Front Pediatr. 2020 Nov 24;8:593455
pubmed: 33330288
Clin Infect Dis. 2020 Dec 3;71(9):2469-2479
pubmed: 32392337
Expert Rev Anti Infect Ther. 2017 Jul;15(7):713-721
pubmed: 28425828
Diagnostics (Basel). 2021 Sep 08;11(9):
pubmed: 34573986
Arch Pediatr. 2021 Apr;28(3):242-248
pubmed: 33483192
Child Care Health Dev. 2021 Jan;47(1):128-135
pubmed: 33047842
Int J Gen Med. 2021 Feb 18;14:515-530
pubmed: 33633461
BMJ. 2020 May 18;369:m1983
pubmed: 32423901
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Rev Assoc Med Bras (1992). 2020 Dec;66(12):1679-1684
pubmed: 33331576
PLoS One. 2020 Jan 27;15(1):e0227947
pubmed: 31986167
Infect Drug Resist. 2020 Dec 29;13:4673-4695
pubmed: 33402839
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
Expert Rev Clin Pharmacol. 2021 Jan;14(1):95-103
pubmed: 33252992
Ther Adv Infect Dis. 2020 Dec 7;7:2049936120978095
pubmed: 33335724
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499422
Expert Rev Anti Infect Ther. 2021 Jun 21;:1-10
pubmed: 34128756
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
J Med Virol. 2021 Feb;93(2):1057-1069
pubmed: 32761898
Infect Dis (Auckl). 2021 Jul 31;14:11786337211033870
pubmed: 34376994
Pediatr Pulmonol. 2021 May;56(5):837-848
pubmed: 33428826
Hosp Pediatr. 2020 Sep;10(9):802-805
pubmed: 32518091
Hosp Pract (1995). 2020 Aug;48(3):128-136
pubmed: 32271642
Ther Adv Infect Dis. 2021 May 5;8:20499361211011373
pubmed: 33996074
Antibiotics (Basel). 2021 Aug 02;10(8):
pubmed: 34438985
Acta Paediatr. 2020 Oct;109(10):1930-1931
pubmed: 32557761
Expert Rev Anti Infect Ther. 2021 Oct 6;:1-9
pubmed: 34591720
J Res Pharm Pract. 2019 Oct 16;8(3):149-154
pubmed: 31728346
Pediatr Res. 2021 Mar;89(4):733-737
pubmed: 32555539
BMJ. 2021 Apr 1;373:n747
pubmed: 33795225
Hosp Pract (1995). 2018 Aug;46(3):128-136
pubmed: 29652559
Inflammopharmacology. 2021 Aug;29(4):1001-1016
pubmed: 34110533
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
J Chemother. 2020 Dec;32(8):456-459
pubmed: 32114964
Elife. 2021 Jun 24;10:
pubmed: 34165077
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
J Pharmacol Pharmacother. 2014 Apr;5(2):83-7
pubmed: 24799810
Int J Clin Pharm. 2020 Aug;42(4):1227-1236
pubmed: 32458227
SN Compr Clin Med. 2021 May 28;:1-5
pubmed: 34095752
JAC Antimicrob Resist. 2020 Oct 22;2(4):dlaa092
pubmed: 34223045
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
BMJ Evid Based Med. 2021 Apr 22;:
pubmed: 33888547
Expert Rev Anti Infect Ther. 2020 Sep;18(9):897-910
pubmed: 32394754
Front Pediatr. 2021 Mar 18;9:625377
pubmed: 33816398
JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001
pubmed: 34222959
Vaccine. 2021 Jan 22;39(4):667-677
pubmed: 33342635
PLoS One. 2021 Apr 6;16(4):e0249788
pubmed: 33822812
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Nutrients. 2021 Apr 01;13(4):
pubmed: 33916257
Hosp Pract (1995). 2019 Apr;47(2):88-95
pubmed: 30963821
J Antimicrob Chemother. 2018 Apr 1;73(4):844-851
pubmed: 29340609
J Antimicrob Chemother. 2017 Mar 1;72(3):923-932
pubmed: 27999033
J Glob Antimicrob Resist. 2020 Sep;22:317-324
pubmed: 32247077
J Antimicrob Chemother. 2016 Aug;71(8):2295-9
pubmed: 27121400
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Lancet. 2020 Oct 24;396(10259):1345-1352
pubmed: 33031764
Infect Drug Resist. 2020 Dec 29;13:4713-4738
pubmed: 33402841
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1495-1500
pubmed: 34710074
Lancet Infect Dis. 2021 Jul;21(7):913
pubmed: 33798486
J Res Pharm Pract. 2021 May 13;10(1):17-22
pubmed: 34295848
Antibiotics (Basel). 2021 Aug 07;10(8):
pubmed: 34439004
Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293
pubmed: 30755077
Arch Dis Child. 2021 Feb 16;:
pubmed: 33593743
BMJ Open. 2020 Mar 31;10(3):e030823
pubmed: 32234736